We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.99B
AUM Growth
-$13.9M
Cap. Flow
-$131M
Cap. Flow %
-1.88%
Top 10 Hldgs %
60.07%
Holding
150
New
17
Increased
52
Reduced
37
Closed
23

Top Buys

Rank Stock Value
1
ST icon
Sensata Technologies
ST
+$183M
2
CI icon
Cigna
CI
+$17.5M
3
COO icon
Cooper Companies
COO
+$16.5M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$12.3M
5
BABA icon
Alibaba
BABA
+$10.9M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$228M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$53.3M
3
VTRS icon
Viatris
VTRS
+$20.6M
4
HDB icon
HDFC Bank
HDB
+$16.9M
5
PFE icon
Pfizer
PFE
+$16.4M

Sector Composition

Rank Sector Weight
1 Financials 33.54%
2 Healthcare 25.68%
3 Communication Services 15.95%
4 Consumer Discretionary 11.33%
5 Industrials 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
26
Centene
CNC
$31.3B
$27.9M 0.4%
693,200
+59,600
+9% +$2.14M
IBN icon
27
ICICI Bank
IBN
$107B
$26.8M 0.38%
2,824,459
+75,240
+3% +$707K
CEMP
28
DELISTED
Cempra, Inc.
CEMP
$25.9M 0.37%
754,300
+184,300
+32% +$6.52M
TTPH
29
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$23.3M 0.33%
24,600
+300
+1% +$245K
EGRX
30
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$22.6M 0.32%
279,407
+145,000
+108% +$9.45M
MRK icon
31
Merck
MRK
$322B
$21M 0.3%
385,870
-104,800
-21% -$5.88M
CI icon
32
Cigna
CI
$78.9B
$20.5M 0.29%
+126,600
New +$17.5M
COR icon
33
Cencora
COR
$62.3B
$20.3M 0.29%
191,200
+4,300
+2% +$484K
ESRX
34
DELISTED
Express Scripts Holding Company
ESRX
$19M 0.27%
213,701
+9,100
+4% +$795K
PFE icon
35
Pfizer
PFE
$144B
$18.8M 0.27%
589,518
-502,758
-46% -$16.4M
JAZZ icon
36
Jazz Pharmaceuticals
JAZZ
$16B
$17.9M 0.26%
101,787
+1,000
+1% +$180K
ABBV icon
37
AbbVie
ABBV
$470B
$17.5M 0.25%
260,000
– –
COO icon
38
Cooper Companies
COO
$14.2B
$16.3M 0.23%
+367,200
New +$16.5M
TEVA icon
39
Teva Pharmaceuticals
TEVA
$40B
$13.9M 0.2%
236,000
+200,000
+556% +$12.3M
HCA icon
40
HCA Healthcare
HCA
$90.9B
$13.5M 0.19%
149,275
– –
AIRM
41
DELISTED
Air Methods Corp
AIRM
$13.4M 0.19%
325,136
-10,000
-3% -$438K
CMRX
42
DELISTED
Chimerix, Inc.
CMRX
$12.7M 0.18%
274,000
+29,000
+12% +$1.16M
SHPG
43
DELISTED
Shire pic
SHPG
$11.2M 0.16%
46,209
– –
BABA icon
44
Alibaba
BABA
$274B
$10.4M 0.15%
+126,320
New +$10.9M
BMRN icon
45
BioMarin Pharmaceuticals
BMRN
$12B
$10.2M 0.15%
74,885
– –
BIDU icon
46
Baidu
BIDU
$35.5B
$10.1M 0.14%
50,625
+1,710
+3% +$350K
ZBH icon
47
Zimmer Biomet
ZBH
$18.6B
$8.68M 0.12%
81,824
– –
NKE icon
48
Nike
NKE
$63.2B
$8.23M 0.12%
152,480
+2,400
+2% +$123K
DVA icon
49
DaVita
DVA
$15.5B
$7.83M 0.11%
98,491
– –
ALXN
50
DELISTED
Alexion Pharmaceuticals
ALXN
$7.6M 0.11%
42,061
-4,600
-10% -$794K
1
2
3 4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2015 Portfolio in Review

As of Q2 2015, C WorldWide Group held 150 positions worth $6.99B, down 0.2% from $7B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

C WorldWide Group's Q2 2015 filing shows 17 new, 52 increased, 37 reduced and 23 closed positions. Its largest new stake was Sensata Technologies: 3,260,860 shares worth $172M. The largest sale was Praxair Inc, an estimated $228M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.

  • C WorldWide Group's largest Q2 2015 buy was Sensata Technologies: 3,260,860 shares worth $172M.
  • C WorldWide Group added most to Teva Pharmaceuticals in Q2 2015, an estimated $12.3M increase.
  • C WorldWide Group's biggest Q2 2015 reduction was Alphabet (Google) Class C, cutting an estimated $53.3M.
  • C WorldWide Group fully exited Praxair Inc in Q2 2015, selling an estimated $228M.
  • C WorldWide Group's ten largest holdings make up 60% of its $6.99B portfolio in Q2 2015.
  • C WorldWide Group opened 17 new positions and closed 23 in Q2 2015.
  • C WorldWide Group's portfolio value fell 0.2% quarter-over-quarter to $6.99B.

Based on C WorldWide Group's 13F filing for Q2 2015, filed 21 Jul 2015.